Clorox (NYSE:CLX) Stock Price Expected to Rise, UBS Group Analyst Says

Clorox (NYSE:CLX) had its price target upped by investment analysts at UBS Group from $96.00 to $100.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective indicates a potential upside of 1.45% from the stock’s previous close.

Other equities research analysts also recently issued reports about the company. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Jefferies Financial Group dropped their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Citigroup lowered their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. dropped their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average price target of $103.67.

Clorox Stock Performance

Shares of CLX traded up $1.62 on Thursday, reaching $98.57. 759,490 shares of the stock traded hands, compared to its average volume of 2,544,406. The firm has a market cap of $11.92 billion, a price-to-earnings ratio of 16.01, a P/E/G ratio of 0.45 and a beta of 0.54. Clorox has a 12 month low of $84.70 and a 12 month high of $132.03. The stock’s 50-day moving average price is $94.38 and its 200-day moving average price is $104.07. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the company posted $1.45 EPS. The business’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts forecast that Clorox will post 5.52 EPS for the current fiscal year.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Clorox

Several large investors have recently bought and sold shares of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Woodline Partners LP increased its holdings in Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after purchasing an additional 7,465 shares during the last quarter. Baird Financial Group Inc. increased its holdings in Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after purchasing an additional 424 shares during the last quarter. Jump Financial LLC lifted its stake in Clorox by 173.5% in the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after buying an additional 7,924 shares during the period. Finally, Bank of Nova Scotia lifted its stake in Clorox by 26.2% in the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after buying an additional 3,352 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.